Innovative, long-acting treatments – for patients and society
Camurus is committed to improving the lives of patients with severe and chronic diseases
Learn more
Disease areas
Focus on severe and chronic diseases
Developing treatments for diseases within the central nervous system, rare diseases, endocrinology, oncology and supportive care.
Events
Upcoming events
-
25Aug
Handelsbanken Life Science Innovation Day
Camurus’ President & CEO Fredrik Tiberg is presenting at this virtual conference, 25 August, at 10.00am CET. The presentation can be seen by the conference participants.
-
02Sep
Pareto Securities’ 17th Annual Healthcare Conference
Camurus’ Chief Business Development Officer Fredrik Joabsson is presenting at this conference in Stockholm, 2 September, at 9.30am CET. The presentation can be seen by the conference participants.
-
14Sep
Morgan Stanley Annual Global Healthcare Conference
Camurus’ Chief Business Development Officer Fredrik Joabsson is presenting at this conference in New York, 14 September, at 10.05pm CET. The presentation can be seen by the conference participants.
Annual General Meeting
Camurus’ Annual General Meeting 2026 was held on 28 May 2026 in Lund, Sweden.
See documents for Annual General Meeting 2026
See more information on Camurus general meetings
Latest financial report
Camurus’ Interim Report Second Quarter 2026
15 July 2026
Annual Report 2025
Pipeline
Diversified pipeline with large potential
Camurus’ innovative product candidates are designed to address important unmet medical needs, with the potential to make significant difference in the daily life of patients by improving treatment outcomes, quality of life, and long-term recovery.
Sustainability
Sustainable solutions for a healthier world
Ensuring the long-term successful development of our business – for the benefit of patients, healthcare systems, employees and shareholders.
